|
Market Closed -
Nasdaq
21:00:00 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 7.400 USD | -0.94% |
|
-3.14% | +77.88% |
| 08-24 | Precision BioSciences, Inc. Commences Dosing In Phase 1/2 Function-Dmd Study | CI |
| 08-24 | Precision BioSciences Doses First Patient in Trial of Potential Duchenne Muscular Dystrophy Treatment | MT |
| Market Cap | 204M 176M 165M 151M 281M 19.36B 283M 1.96B 757M 9.9B 767M 750M 31.5B | P/E 2026 * |
-2.05x | P/E 2027 * | -2.73x |
|---|---|---|---|---|---|
| Enterprise Value | 204M 176M 165M 151M 281M 19.36B 283M 1.96B 757M 9.9B 767M 750M 31.5B | EV / Sales 2026 * |
15.1x | EV / Sales 2027 * | 23x |
| Free-Float |
91.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DTIL | Delayed | |
CBOE
| DTIL | Real-time | |
|
Deutsche Boerse AG
| PBS0 | Delayed | |
|
Tradegate
| PBS0 | Real-time | |
|
Boerse Muenchen
| PBS0 | Real-time | |
|
Börse Stuttgart
| PBS0 | Delayed |
Last Transcript : Precision BioSciences, Inc.
| 1 day | -0.94% | ||
| 1 week | -3.14% | ||
| Current month | -3.14% | ||
| 1 month | -1.20% | ||
| 3 months | +9.31% | ||
| 6 months | +60.52% | ||
| Current year | +77.88% |
| 1 week | 7.2 |  | 7.58 |
| 1 month | 7.18 | | 9.34 |
| Current year | 3.53 | | 9.62 |
| 1 year | 3.53 | | 9.62 |
| 3 years | 3.53 | | 19.43 |
| 5 years | 3.53 | | 404.66 |
| 10 years | 3.53 | | 710.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 48 | 14/10/2021 |
Jeff Smith
CTO | Chief Tech/Sci/R&D Officer | 53 | 25/01/2006 |
Naresh Tanna
DFI | Director of Finance/CFO | 45 | 31/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Buehler
CHM | Chairman | 68 | 31/10/2020 |
Geno Germano
BRD | Director/Board Member | 65 | 09/03/2020 |
Stanley Frankel
BRD | Director/Board Member | 67 | 11/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/08/26 | Other | Chief Financial Officer | 251,581 | 1.0451% | ||
| 01/08/26 | Other | Controller/Auditor | 48,872 | 0.2030% | ||
| 01/08/26 | Other | Chief Technology Officer | 236,188 | 0.9812% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.94% | -3.14% | +48.89% | -40.56% | 204M | |
| -3.17% | -7.92% | -5.49% | +10.26% | 48.01B | |
| -1.29% | -1.22% | +404.92% | +545.45% | 44.44B | |
| -3.20% | +0.33% | +38.11% | +21.39% | 42.67B | |
| -1.89% | -2.00% | +1.45% | +82.46% | 39.96B | |
| -1.72% | -2.61% | +13.09% | +42.33% | 32.75B | |
| -0.17% | +3.78% | - | - | 17.74B | |
| -0.07% | +1.32% | +20.08% | +117.95% | 16.49B | |
| +0.20% | -1.98% | +11.54% | +31.67% | 14.38B | |
| -2.68% | -0.56% | +73.31% | +40.56% | 13.4B | |
| Average | -1.51% | -0.75% | +67.32% | +94.61% | 27B | |
| Weighted average by Cap. | -1.93% | -1.05% | +84.55% | +131.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.48M 11.59M 10.91M 9.95M 18.58M 1.28B 18.67M 129M 50M 653M 50.64M 49.53M 2.08B | 8.88M 7.63M 7.18M 6.55M 12.23M 841M 12.29M 85.06M 32.91M 430M 33.33M 32.6M 1.37B |
| Net income | -94.18M -80.98M -76.18M -69.52M -130M -8.93B -130M -903M -349M -4.56B -354M -346M -14.52B | -96.95M -83.35M -78.42M -71.56M -134M -9.19B -134M -929M -359M -4.7B -364M -356M -14.95B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | US$7.400 | -0.94% | 139,956 |
| 04/09/26 | US$7.470 | +1.36% | 124,284 |
| 03/09/26 | US$7.370 | -1.07% | 186,994 |
| 02/09/26 | US$7.450 | -2.49% | 358,921 |
| 01/09/26 | US$7.640 | 0.00% | 170,933 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DTIL Stock
Select your edition
All financial news and data tailored to specific country editions
